Wegovy obesity drug sales more than double but set to slow
Sales of Wegovy, a prescription weight loss injection, surged to 19.9 billion Danish kroner (£2.2 billion) in the fourth ...
Novo Nordisk's next-gen obesity drug Cagrisema: investors seek answers
Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...
Axios on MSN1d
Super Bowl ads spotlight health and body positivity
Thomas Oide/Axios A slew of advertisers are bringing a healthier and more female-focused message to this year's big game, with spots highlighting everything from breast cancer awareness to obesity and ...
BMJ1d
Associations between caregivers health behaviours and overweight/obesity among children aged 2-6 years in Beijing, China: a cross-sectional study
Objective To investigate the correlation between caregivers’ health-related behaviours and the prevalence of ...
Forget Wegovy: Novo Nordisk May Have a New Billion-Dollar Weight Loss Drug On Its Hands
Drugmakers have poured small fortunes into the development of weight loss medicines in the past few years in attempts to lead ...
SW Londoner5d
NHS semaglutide spending in London tops £15m
NHS semaglutide spending in London has surged from £242K in 2019 to £15.6m in 2024. Find out what's driving demand and the ...